PVCT
Provectus Biopharmaceuticals, Inc.Company with tickers: PVCT
CIK
315545
CUSIP
74373P108
Shares Outstanding
420,279,879
Price History
Institutional Holders
Short Volume
Short Interest
Fails to Deliver
Financials
SEC Filings
Earnings Calls
Insider Trades
Congressional Trades
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | — | ||||
| Revenue (ASC 606) | — | ||||
| Cost of Revenue | — | ||||
| Gross Profit | — | ||||
| Operating Expenses | $1,247,903 | USD | 2026-03-31 | 10-Q | 2026-05-14 |
| Research & Development | $333,334 | USD | 2026-03-31 | 10-Q | 2026-05-14 |
| Operating Income | $-1,247,903 | USD | 2026-03-31 | 10-Q | 2026-05-14 |
| Net Income | $-1,290,454 | USD | 2026-03-31 | 10-Q | 2026-05-14 |
| EPS (Basic) | $0.00 | USD/shares | 2026-03-31 | 10-Q | 2026-05-14 |
| EPS (Diluted) | $0.00 | USD/shares | 2026-03-31 | 10-Q | 2026-05-14 |